GELPHORM
LIVE

Serial Number

79274601

Owner

Clover Corporation Limited

Attorney

Nicholas J. Gingo

Filing Date

Sep 4, 2019

Add to watchlist:

No watchlists yet
View on USPTO

GELPHORM Trademark

Serial Number: 79274601 • Registration: 6450815

GELPHORM is a trademark filed by Clover Corporation Limited on September 4, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). The application is currently registered and active.

Owner Contact Info

Clover Corporation Limited (15 trademarks)

Unit 16, 3 Vuko Place,
Warriewood, NSW 2102 , AU

Entity Type: 03

Trademark Details

Filing Date

September 4, 2019

Registration Date

August 17, 2021

Published for Opposition

June 1, 2021

Goods & Services

Flour; wheat flour; corn flour; preparations made from cereals and cereal preparations, namely, cereal-based snack food and cereal-based snack bars; bread, bread rolls and buns; cakes; pastry; frozen confectionery; edible ices; yeast; savory sauces used as condiments; biscuits; custard; farinaceous food pastes for human consumption; food flavoring agents, namely, syrup for flavoring food and extracts used as food flavoring; ice cream; pasta

Edible oils and fats; edible oils and fats in the nature of omega-3 (dha) oils and oils from fish, algae and plant sources, namely, those in edible oil form; milk; milk products excluding ice cream, ice milk and frozen yogurt; milk products, namely, cheese and yogurt; modified milk, namely, fortified milk containing increased levels of vitamins, minerals, and other nutritional additives; filled milk, namely, milk containing edible oils and fats in the nature of omega-3 (dha) oils and oils from fish, algae and plant sources, namely, those in edible oil form; powdered milk; cream

Dietetic substances for medical purposes, namely, dietetic foods adapted for medical use, diabetic foods in the nature of diabetic bread adapted for medical purposes, dietary supplements, medicated lyophilized food adapted for medical purposes, and dietetic foods and beverages adapted for medical use; biological and dietary food preparations for medical purposes, namely, nutritional supplements in the form of powder and tablets consisting of dried fruits and vegetables; food supplements; food supplements, namely, nutritional supplements and protein supplements consisting of dairy based fat and protein; food additives for medical purposes, namely, glucose for use as an additive to foods for medical purposes and lecithin for medical purposes; baby and infant formula; medicinal oils in the nature of fish oils, cod liver oil, tuna oil and evening primrose oil; micro-encapsulated medicinal oils for medical purposes, not in gel capsule form; emulsified medicinal oils for medical purposes; nutritional and dietetic substances for medical purposes, namely, nutritional supplements in the form of tablets; all the aforesaid excluding homeostatic agents and products in gel form

Stabilizers for food products or used in the manufacture of foodstuffs for human use, namely, chemical products for stabilizing foodstuffs for human use and dough stabilizers; emulsifiers for food products or used in the manufacture of foodstuffs for human use, namely, emulsifiers for use in the manufacture of foods for human use and brominated vegetable oil for use as an emulsifier in the manufacture of foods for human use; texture modifying agents for food products or used in the manufacture of foodstuffs for human use, namely, chemical thickeners for use in the manufacture of foods for human use; preservatives for food products or used in the manufacture of foodstuffs for human use, namely, food preservatives; oils for the preservation of food; oils for the preservation of food in the nature of omega-3 (dha) oils and oils from fish, algae and plant sources, namely, those in oil form; texturizers for food products or used in the manufacture of foodstuffs for human use, namely, chemical additives for use as binding agents in food products for human use; food and beverage additives used in the manufacture of foodstuffs for human use, namely, pectin for the food industry, lecithin for the food industry, gluten for the food industry, glucose for the food industry, alginates for the food industry and cream of tartar for the food industry; proteins for the food industry derived from dairy based fat and protein fractions for use in the manufacture of food for human use; chemical substances for use in the food industry, namely, food preserving chemicals and mold inhibiting chemicals for treating foods; chemicals and preparations used in the manufacturing or processing of food, namely, chemical additives for use in the manufacture of food; glucose for industrial purposes; gluten for industrial purposes; glucose syrup for industrial purposes; maltodextrins derived from tapioca starch for industrial purposes; fermented preparations consisting of cultures of microorganisms for use in the manufacture of food, other than for medical and veterinary use; chemical preparations for use in the food industry in the nature of food ingredients, food preparations, food stabilizers, food emulsifiers and food texture modifying agents, namely, chemical products for industrial purposes in the form of fat-replacers for food in liquid or dry form, chemical additives for use in the manufacture of food in liquid or dry form and chemical products for the fresh-keeping and preserving of food in liquid or dry form; chemical additives for use in the manufacture of food in the form of liquids, tablets, pastes or powders, not for medical purposes; casein for the food industry; all the aforesaid excluding homeostatic agents, agents for sterilizing a surgical sponge, agents for regulating blood flow, agents for sterile surgical sponges, and products in gel form

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 24, 2022 FICS
FINAL DISPOSITION PROCESSED
Jan 24, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 17, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 17, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 6, 2021 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 1, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 1, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 30, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 19, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 19, 2021 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 12, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 12, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 12, 2021 NONP
EXPARTE APPEAL TERMINATED
Apr 26, 2021 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 26, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 26, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 26, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 26, 2021 CNEA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 26, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Feb 26, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Feb 26, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Feb 26, 2021 EXAF
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2021 NREP
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 31, 2020 GNFN
FINAL REFUSAL E-MAILED
Aug 31, 2020 GNFR
FINAL REFUSAL WRITTEN
Aug 31, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2020 TROA
REFUSAL PROCESSED BY IB
Feb 28, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 7, 2020 RFCS
REFUSAL PROCESSED BY MPU
Feb 7, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 17, 2020 RFCR
NON-FINAL ACTION WRITTEN
Jan 16, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 7, 2020 MAFR
ASSIGNED TO EXAMINER
Jan 3, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2019 REPR